SHOP APOTH. UNSP.ADR/010 (F:SAE1) — Stock Price
SHOP APOTH. UNSP.ADR/010 (F:SAE1) is currently trading at €4.54 EUR, down 4.62% today. Over the past 52 weeks, shares have ranged between €2.50 and €12.90. This page tracks SHOP APOTH. UNSP.ADR/010's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see SHOP APOTH. UNSP.ADR/010 cash flow conversion.
SHOP APOTH. UNSP.ADR/010 (SAE1) Stock Price Chart — Daily History & Trading Volume
The chart below tracks SHOP APOTH. UNSP.ADR/010's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
SHOP APOTH. UNSP.ADR/010 Income Statement — Revenue, Profit & Earnings by Year
SHOP APOTH. UNSP.ADR/010's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €2.94 Billion | €2.37 Billion | €1.80 Billion | €1.20 Billion | €1.06 Billion |
| Cost of Revenue | €2.28 Billion | €1.82 Billion | €1.36 Billion | €872.57 Million | €793.79 Million |
| Gross Profit | €663.10 Million | €545.80 Million | €440.38 Million | €331.79 Million | €266.53 Million |
| Research & Development | — | — | — | — | — |
| SG&A | €427.10 Million | €356.70 Million | €267.44 Million | €244.24 Million | €196.88 Million |
| Total Operating Expenses | €2.97 Billion | €2.41 Billion | €1.82 Billion | €1.27 Billion | €1.13 Billion |
| Operating Income | €-29.80 Million | €-39.00 Million | €-17.30 Million | €-69.32 Million | €-65.86 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €19.90 Million | €7.80 Million | €8.00 Million | €8.50 Million | €8.57 Million |
| Income Before Tax | €-47.70 Million | €-47.90 Million | €-14.35 Million | €-84.12 Million | €-77.88 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-37.70 Million | €-45.50 Million | €-12.04 Million | €-77.65 Million | €-74.19 Million |
SHOP APOTH. UNSP.ADR/010 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes SHOP APOTH. UNSP.ADR/010's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €1.21 Billion | €1.00 Billion | €1.02 Billion | €729.47 Million | €783.08 Million |
| Total Current Assets | €619.40 Million | €500.02 Million | €499.52 Million | €343.92 Million | €432.76 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €111.10 Million | €80.66 Million | €120.00 Million | €113.32 Million | €36.41 Million |
| Net Receivables | €129.50 Million | €109.80 Million | €103.13 Million | €30.00 Million | €27.92 Million |
| Inventory | €214.00 Million | €153.82 Million | €135.79 Million | €99.71 Million | €96.62 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | €276.20 Million | €277.50 Million | €277.50 Million | €169.57 Million | €153.13 Million |
| Total Liabilities | €735.10 Million | €493.31 Million | €469.56 Million | €374.84 Million | €367.66 Million |
| Total Current Liabilities | €400.00 Million | €249.73 Million | €223.72 Million | €119.31 Million | €124.08 Million |
| Long-term Debt | €261.90 Million | €209.97 Million | €205.39 Million | €220.06 Million | €203.97 Million |
| Net Debt | €246.10 Million | €114.99 Million | €123.24 Million | €154.91 Million | — |
| Total Stockholder Equity | €459.20 Million | €483.98 Million | €522.19 Million | €354.63 Million | €415.41 Million |
| Retained Earnings | €-358.20 Million | €-324.29 Million | €-279.26 Million | €-285.43 Million | €-207.78 Million |
SHOP APOTH. UNSP.ADR/010 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how SHOP APOTH. UNSP.ADR/010 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €31.00 Million | €22.10 Million | €61.46 Million | €-29.11 Million | €11.63 Million |
| Capital Expenditures | €118.60 Million | €42.10 Million | €38.22 Million | €53.52 Million | €43.16 Million |
| Free Cash Flow | €-87.60 Million | €-20.00 Million | €23.23 Million | €-82.64 Million | €-31.52 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | €3.50 Million | €3.20 Million | €9.00 Million | €16.23 Million | €20.54 Million |
| Depreciation | €69.40 Million | €68.20 Million | €57.29 Million | €39.51 Million | €26.96 Million |
| Change in Cash | €-4.30 Million | €12.60 Million | €16.54 Million | €-180.64 Million | €156.93 Million |
SHOP APOTH. UNSP.ADR/010 Earnings History — EPS Actual vs. Analyst Estimates
Track SHOP APOTH. UNSP.ADR/010's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Oct 29, 2025 | — | — | — |
| Jul 29, 2025 | — | — | — |
| May 06, 2025 | — | — | — |
| Nov 05, 2024 | — | — | — |